New immune cell therapy benefits laboratory models of ALS and has some positive results in an individual with the disease Post author: Post published:July 11, 2024 Post category:News Feed Post comments:0 Comments The study provides the basis for a phase I clinical trial in additional participants. You Might Also Like Scientists debunk role of ‘junk cells’ in fight against malaria February 9, 2024 Mediterranean diet tied to one-fifth lower risk of early death in women June 1, 2024 Micro- and nanoplastics in the body are passed on during cell division March 8, 2024 Leave a Reply Cancel replyCommentEnter your name or username to comment Enter your email address to comment Enter your website URL (optional) Save my name, email, and website in this browser for the next time I comment.